Revenue segments as reported by the company.

Electronics & Industrial

Water & Protection

Corporate & Other

Mobility & Materials

Corporate

Electronics & Imaging

Nutrition & Biosciences

Transportation & Industrial

Safety & Construction

Non-Core

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development expenses

Selling, general and administrative expenses

Amortization of intangibles

Restructuring and asset related charges - net

Goodwill impairment charges

Acquisition, integration and separation costs

Equity in earnings of nonconsolidated affiliates

Sundry income (expense) - net

Interest expense

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

DuPont de Nemours

Danisco is a Danish bio-based company with activities in food production, enzymes and other bioproducts as well as a wide variety of pharmaceutical grade excipients. It was formed in 1989 from the largest Danish industrial merger ever of the two old C.F. Tietgen companies Danish Sugar (founded 1872), and Dansk Handels- og Industri Company (Danisco A/S).

Danisco

Solae was an international soy ingredients supplier based in St. Louis, Missouri. Solae was formed as a joint venture between DuPont and Bunge Limited. On May 1, 2012, Solae announced that DuPont had acquired Bunge's 28% share, thus taking full ownership of the company. DuPont then merged Solae's business into Danisco. The company developed food, feed and industrial ingredients, focusing on soy. Many of the studies supporting the Food and Drug Administration-approved health claim were based on research using Solae soy protein.

Solae

DuPont de Nemours, Inc. is a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics and Industrial, Water and Protection, and Corporate and Others. The Electronics and Industrial segment involves the supply of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The Water and Protection segment focuses on the provision of engineered products and integrated systems for many industries including worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The company was founded in 1897 and is headquartered in Wilmington, DE.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

DuPont reports strong Q4 results, eyes growth amid challenges

DuPont's Q4 performance showcased organic revenue growth and margin improvement, supported by strategic actions and portfolio transformation.
While facing challenges in the shelter business and market conditions, DuPont remains focused on innovation, growth opportunities, and shareholder value enhancement.
The company's outlook for 2023 includes solid top-line growth, operational targets, and a strategic focus on managing challenges and leveraging growth opportunities.

DuPont exceeds Q1 expectations, eyes healthcare growth amid market challenges

DuPont's Q1 performance was solid, with revenue and adjusted EPS surpassing guidance, driven by acquisitions and ongoing market strengths. Challenges in the electronics market and inventory destocking impacted full-year guidance, but opportunities for growth in healthcare and other sectors are on the horizon. The company's focus on sustainability and operational efficiency remains key.

DuPont reports resilient Q2 performance amidst market challenges

DuPont's Q2 performance showed resilience amid market challenges, with a focus on strategic priorities for long-term growth.
While facing volume pressures and market uncertainties, DuPont is leveraging acquisitions and cost controls to drive value.
Opportunities lie in sequential business improvements, cost reductions, and sustainability-focused sales strategies.
Challenges include market-specific declines and regional growth variations that require strategic adjustments.

DuPont reports solid Q3 earnings amidst China challenges and growth opportunities

DuPont's Q3 performance showcased resilience amid challenges, with revenue declines offset by improved margins and EPS growth. Strategic acquisitions and divestitures are driving the company forward.
Despite facing headwinds in China and inventory destocking, DuPont is capitalizing on opportunities in semiconductors and other key segments. Efforts to enhance efficiency and target growth areas position the company for future success.
While challenges like trade restrictions and industrial destocking persist, DuPont remains focused on leveraging growth opportunities in AI, electronics, and other segments. Maintaining a strong cash position and returning value to shareholders are key priorities.

DuPont reports Q4 2023 results, eyes growth in key markets

DuPont's Q4 performance saw declines in net sales and EBITDA, but the company remains resilient amidst market challenges. Cost-saving initiatives and share repurchase programs demonstrate strategic financial management.
Despite absorption headwinds and challenges in China, DuPont's focus on key markets like semiconductors and water positions it for growth. The company's long-term EBITDA margin outlook is positive.
Opportunities in market stabilization, recovery in key sectors, and potential growth in water and electronics segments offer DuPont avenues for future expansion and profitability.

DuPont surpasses Q1 expectations, eyes growth amid market challenges

DuPont's Q1 2024 performance exceeded expectations, prompting an upward revision of full-year guidance across key financial metrics.
The company's focus on operational excellence, sustainability, and market diversification positions it well for recovery and growth in 2024 and beyond.
While facing challenges in pricing and market dynamics, DuPont's strategic initiatives and opportunities in key segments offer avenues for future growth.
Overall, DuPont's strong performance, prudent risk management, and focus on innovation and efficiency underscore its resilience and potential for sustained success.

DuPont surpasses Q2 expectations, eyes growth in tech and China

DuPont delivered strong Q2 2024 results, exceeding guidance and showcasing resilience across key segments.
Strategic initiatives like the Donatelle acquisition and planned separation activities position DuPont for future growth and market leadership.
While legal challenges persist, DuPont's proactive approach and focus on innovation and diversification bode well for long-term success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

WILMINGTON, Del., Oct. 14, 2020 /PRNewswire/ -- DuPont's board of directors declared a fourth quarter dividend of $0.30 per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable December 15, 2020, to holders of record of said stock at the close of...

DuPont Declare Regular Quarterly Dividend on Common Stock

Genuine Parts

Newell Brands

Sealed Air

Target

Investors seeking both growth and income in stocks can venture out to the market, at present, to make profitable investment decisions.

5 Top S&P 500 Stocks to Bet on for Income & Growth Investors

Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

5 Top DuPont-Driven Stocks to Counter Stimulus Uncertainty

Axalta Coating Systems

Axalta Coating Systems Ltd. (NYSE: AXTA) may not be the most exciting stock in a world that is paying 50 and 100 times revenues for new hot growth companies that are losing money.

Why DuPont Is Called to Rise 25% and Axalta Could See 35% Upside

Why you should depend on the DuPont technique to pick solid profit-generating stocks.

5 DuPont-Rich Quality Picks to Handle Sudden Sell-Off

VALENCIA, Calif.--(BUSINESS WIRE)--Mechanix Wear, the leader in high-performance hand protection, announced today that they are an official licensee of DuPont Personal Protection, a global innovation leader with technology-based materials, ingredients and solutions.

Mechanix Wear Partners with DuPont Personal Protection to Expand Glove Technology

NEW YORK & WILMINGTON, Del.--(BUSINESS WIRE)---- $IFF--Regulatory News: IFF (NYSE:IFF) (Euronext Paris:IFF) (TASE:IFF) and DuPont (NYSE:DD) announced today that Nutrition & Biosciences, Inc.

IFF & DuPont Announce Pricing of $6.25 Billion Senior Notes Offering by Nutrition & Biosciences, Inc.

The partnership supports DuPont's (DD) goal to boost access of products and technologies required to address global challenges.

DuPont Inks Degasification Deal With Sun Chemical & DIC Corp

Have more faith in DuPont analysis than simple ROE calculation?  Bet on these five stocks.

5 Top-Ranked Stocks Picked on DuPont Analysis

Caterpillar

Starbucks

On CNBC's "Fast Money," Carter Worth said that the S&P 500 is making all-time highs and yet 50% of the index has made no progress in two years.

Carter Worth Shares His Latest Catch-Up Trades: Caterpillar, Starbucks And More

NEW YORK & WILMINGTON, Del.--(BUSINESS WIRE)---- $IFF--Regulatory News: IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF) and DuPont (NYSE: DD) announced that, during a special meeting held earlier today, IFF shareholders voted to approve the issuance of shares of IFF common stock in connection with the previously announced proposed merger of IFF and DuPont’s Nutrition & Biosciences (N&B) business pursuant to a Reverse Morris Trust transaction.

IFF Shareholders Approve Merger with DuPont’s Nutrition & Biosciences Business

Play DuPont Technique to Bet on 5 Top-Ranked Stocks

WILMINGTON, Del., Aug. 25, 2020 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has named 12 outstanding scientists as recipients of the Lavoisier Medal of Technical Achievement and the Pedersen Award Medal.

DuPont Names Lavoisier and Pedersen Award Medalists

Honeywell

"I suspect the cyclicals, industrials and banks could lead us from here, not the Covid stocks, although that doesn't mean they'll get destroyed," the "Mad Money" host said.

Jim Cramer says it's time to swap pandemic plays for the recovery stocks

Bet on six top-ranked stocks with higher ROE derived the DuPont way.

6 Must-Buy Quality Stocks Screened on DuPont Analysis

DuPont de Nemours' (DD) CEO Ed Breen on Q2 2020 Results - Earnings Call Transcript

Shares of DuPont de Nemours (NYSE:DD) fell 1.1% in pre-market trading after the company reported Q2 results.

DuPont de Nemours: Q2 Earnings Insights

DuPont's (DD) adjusted earnings of 70 cents per share for Q2 beat the Zacks Consensus Estimate of 59 cents.

DuPont (DD) Beats Q2 Earnings and Revenue Estimates

DuPont de Nemours Inc. DD, +2.79% said Thursday it had a net loss of $2.478 billion, or $3.37 a share, in the second quarter, wider than the loss of $571 million, or $1.48 a share, posted in the year-earlier period.

DuPont loss widens as revenue falls 12% in Q2, books non-cash charge related to slowdown in car market

DuPont reported a wider second-quarter loss on Thursday and wrote down the value of its automotive business by $2.5 billion as the industrial materials giant struggles with a prolonged weakness in one of its biggest end-markets.

DuPont takes $2.5 billion charge tied to auto business, posts wider loss

WILMINGTON, Del., July 30, 2020 /PRNewswire/ -- 2Q20 GAAP EPS from continuing operations of $(3.37); adjusted EPS of $0.70 2Q20 Net Sales of $4.8 billion, down 12 percent; organic sales down 10 percent 2Q20 GAAP Income (Loss) from continuing operations of $(2.5) billion and Operating.

DuPont Reports Second Quarter 2020 Results

DuPont de Nemours (NYSE: DD) announces its next round of earnings this Thursday, July 30.

Earnings Preview: DuPont de Nemours

DUBLIN--(BUSINESS WIRE)--The "Fracking Water Treatment Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering. The global market for fracking water treatment is expected to grow at a CAGR of over 3% during the forecast period.

Global Fracking Water Treatment Market Study 2020-2025 Featuring Agua Dulce Technologies, Aquatech International, DuPont, Ecologix Environmental Systems, and Filtra Systems Amongst Others - ResearchAndMarkets.com

DuPont (DD) aims to incorporate a decline in embodied carbon in an updated Environmental Product Declaration, with the launch of a reduced GWP Styrofoam brand insulation.

News for DuPont de Nemours Stock (DD)